Greenspring Advisors’s CVS Health CVS Stock Holding History

Greenspring Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,048	Closed	-$226K	–	84
2023 Q1	$226K	Buy	+3,048	New	+$256K	0.05%	114

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Greenspring Advisors's CVS Position: Q2 2023 in Review

Greenspring Advisors sold out of CVS Health (CVS) in Q2 2023, closing a stake of 3,048 shares — an estimated $226K sold.

Greenspring Advisors first reported a position in CVS in Q1 2023 and held it in 1 quarter. The position peaked at $226K in Q1 2023. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

Greenspring Advisors reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
Greenspring Advisors sold 3,048 CVS Health shares in Q2 2023, an estimated $226K.
Greenspring Advisors first reported a position in CVS Health in Q1 2023 and held it in 1 quarter.
Greenspring Advisors's CVS Health position peaked at $226K in Q1 2023.
2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Greenspring Advisors's 13F filing for Q2 2023, filed 20 Jul 2023.